logo

Rigel Pharmaceuticals Inc. (RIGL)



Trade RIGL now with
  Date
  Headline
6/12/2018 7:31:12 AM Rigel To Present Oral Presentation On Phase 2 Stage 1 Interim Results For Fostamatinib
5/30/2018 7:31:32 AM Rigel Appoints Dean Schorno EVP And CFO
5/29/2018 7:30:57 AM Rigel Announces Availability Of TAVALISSE In U.S.
5/1/2018 4:04:06 PM Rigel Pharma Q1 Loss Per Share $0.17 Vs Loss $0.13 Last Year
4/30/2018 7:33:55 AM Rigel Pharma: TAVALISSE Phase 3 Data Published In The American Journal Of Hematology
4/19/2018 7:46:31 PM Rigel Announces Pricing Of Public Offering Of Common Stock
4/18/2018 4:36:59 PM Rigel Intends To Offer Up To 15 Mln Shares In Public Offering
4/18/2018 6:36:03 AM Jefferies Is Increasing Rigel Pharmaceuticals Inc. (RIGL) 2020 Estimate To -0.05 From -0.26
4/18/2018 6:35:48 AM Jefferies Is Increasing Rigel Pharmaceuticals Inc. (RIGL) 2019 Estimate To -0.42 From -0.51
4/18/2018 6:34:44 AM Jefferies Is Raising Rigel Pharmaceuticals Inc. (RIGL) 2020 Rev. Estimate To 105.8 M From 67.5 M
4/18/2018 6:34:32 AM Jefferies Is Raising Rigel Pharmaceuticals Inc. (RIGL) 2019 Rev. Estimate To 43.0 M From 26.2 M
4/18/2018 6:34:10 AM Jefferies Is Lowering Rigel Pharmaceuticals Inc. (RIGL) 2018 Rev. Estimate To 6.6 M From 7.4 M
4/17/2018 4:52:45 PM Rigel Announces FDA Approval Of TAVALISSE For Chronic Immune Thrombocytopenia In Adult Patients